nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—epithelium—rectum cancer	0.0728	0.114	CbGeAlD
Pseudoephedrine—SLC6A2—autonomic nervous system—rectum cancer	0.0722	0.113	CbGeAlD
Pseudoephedrine—IL2—renal system—rectum cancer	0.0675	0.106	CbGeAlD
Pseudoephedrine—IL2—female reproductive system—rectum cancer	0.0541	0.0848	CbGeAlD
Pseudoephedrine—TNF—vagina—rectum cancer	0.051	0.08	CbGeAlD
Pseudoephedrine—NFATC1—lymph node—rectum cancer	0.0346	0.0542	CbGeAlD
Pseudoephedrine—SLC6A2—Amine compound SLC transporters—SLC14A2—rectum cancer	0.0337	0.093	CbGpPWpGaD
Pseudoephedrine—TNF—lymph node—rectum cancer	0.033	0.0517	CbGeAlD
Pseudoephedrine—IL2—lymph node—rectum cancer	0.0316	0.0496	CbGeAlD
Pseudoephedrine—SLC6A3—Amine compound SLC transporters—SLC14A2—rectum cancer	0.0298	0.0824	CbGpPWpGaD
Pseudoephedrine—MAOA—seminal vesicle—rectum cancer	0.0165	0.0258	CbGeAlD
Pseudoephedrine—ADRA1A—epithelium—rectum cancer	0.0144	0.0226	CbGeAlD
Pseudoephedrine—ADRB1—female reproductive system—rectum cancer	0.0136	0.0213	CbGeAlD
Pseudoephedrine—ADRA1A—renal system—rectum cancer	0.0134	0.021	CbGeAlD
Pseudoephedrine—MAOA—renal system—rectum cancer	0.0133	0.0208	CbGeAlD
Pseudoephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0132	0.0364	CbGpPWpGaD
Pseudoephedrine—SLC6A4—female reproductive system—rectum cancer	0.0131	0.0205	CbGeAlD
Pseudoephedrine—MAOA—urethra—rectum cancer	0.013	0.0204	CbGeAlD
Pseudoephedrine—ADRA2A—seminal vesicle—rectum cancer	0.0126	0.0198	CbGeAlD
Pseudoephedrine—MAOA—mammalian vulva—rectum cancer	0.0124	0.0194	CbGeAlD
Pseudoephedrine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0117	0.0322	CbGpPWpGaD
Pseudoephedrine—SLC6A2—female reproductive system—rectum cancer	0.0115	0.0181	CbGeAlD
Pseudoephedrine—MAOA—female reproductive system—rectum cancer	0.0106	0.0167	CbGeAlD
Pseudoephedrine—ADRA2A—urethra—rectum cancer	0.01	0.0157	CbGeAlD
Pseudoephedrine—MAOA—vagina—rectum cancer	0.00961	0.0151	CbGeAlD
Pseudoephedrine—ADRA2A—mammalian vulva—rectum cancer	0.00952	0.0149	CbGeAlD
Pseudoephedrine—IL2—Interleukin receptor SHC signaling—HRAS—rectum cancer	0.00834	0.023	CbGpPWpGaD
Pseudoephedrine—ADRB2—Arf6 trafficking events—ITGA2—rectum cancer	0.00823	0.0227	CbGpPWpGaD
Pseudoephedrine—ADRA2A—female reproductive system—rectum cancer	0.00815	0.0128	CbGeAlD
Pseudoephedrine—CYP2D6—renal system—rectum cancer	0.00788	0.0124	CbGeAlD
Pseudoephedrine—IL2—Interleukin-2 signaling—NRAS—rectum cancer	0.00754	0.0208	CbGpPWpGaD
Pseudoephedrine—IL2—IL-5 Signaling Pathway—KRAS—rectum cancer	0.00738	0.0204	CbGpPWpGaD
Pseudoephedrine—ADRA2A—vagina—rectum cancer	0.00737	0.0116	CbGeAlD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—NRAS—rectum cancer	0.00679	0.0187	CbGpPWpGaD
Pseudoephedrine—SLC6A2—lymph node—rectum cancer	0.00675	0.0106	CbGeAlD
Pseudoephedrine—IL2—IL2-mediated signaling events—NRAS—rectum cancer	0.00674	0.0186	CbGpPWpGaD
Pseudoephedrine—IL2—Interleukin-2 signaling—KRAS—rectum cancer	0.00649	0.0179	CbGpPWpGaD
Pseudoephedrine—IL2—SHP2 signaling—NRAS—rectum cancer	0.00637	0.0176	CbGpPWpGaD
Pseudoephedrine—CYP2D6—female reproductive system—rectum cancer	0.00631	0.0099	CbGeAlD
Pseudoephedrine—MAOA—lymph node—rectum cancer	0.00621	0.00974	CbGeAlD
Pseudoephedrine—IL2—IL-2 Signaling Pathway—HRAS—rectum cancer	0.00603	0.0167	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00598	0.0165	CbGpPWpGaD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—KRAS—rectum cancer	0.00584	0.0161	CbGpPWpGaD
Pseudoephedrine—IL2—Interleukin-3, 5 and GM-CSF signaling—HRAS—rectum cancer	0.00581	0.016	CbGpPWpGaD
Pseudoephedrine—IL2—IL2-mediated signaling events—KRAS—rectum cancer	0.0058	0.016	CbGpPWpGaD
Pseudoephedrine—IL2—Downstream signaling in naïve CD8+ T cells—NRAS—rectum cancer	0.00574	0.0159	CbGpPWpGaD
Pseudoephedrine—IL2—Interleukin-2 signaling—HRAS—rectum cancer	0.00551	0.0152	CbGpPWpGaD
Pseudoephedrine—IL2—SHP2 signaling—KRAS—rectum cancer	0.00548	0.0151	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.0053	0.0146	CbGpPWpGaD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—HRAS—rectum cancer	0.00497	0.0137	CbGpPWpGaD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—TP53—rectum cancer	0.00496	0.0137	CbGpPWpGaD
Pseudoephedrine—IL2—Downstream signaling in naïve CD8+ T cells—KRAS—rectum cancer	0.00494	0.0136	CbGpPWpGaD
Pseudoephedrine—IL2—IL2-mediated signaling events—HRAS—rectum cancer	0.00493	0.0136	CbGpPWpGaD
Pseudoephedrine—NFATC1—BCR signaling pathway—HRAS—rectum cancer	0.00491	0.0136	CbGpPWpGaD
Pseudoephedrine—ADRA2A—lymph node—rectum cancer	0.00477	0.00748	CbGeAlD
Pseudoephedrine—IL2—SHP2 signaling—HRAS—rectum cancer	0.00466	0.0129	CbGpPWpGaD
Pseudoephedrine—IL2—Folate Metabolism—TP53—rectum cancer	0.00439	0.0121	CbGpPWpGaD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—TP53—rectum cancer	0.00437	0.0121	CbGpPWpGaD
Pseudoephedrine—IL2—Downstream signaling in naïve CD8+ T cells—HRAS—rectum cancer	0.0042	0.0116	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—TP53—rectum cancer	0.00419	0.0116	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—ITGA2—rectum cancer	0.00401	0.0111	CbGpPWpGaD
Pseudoephedrine—NFATC1—TCR Signaling Pathway—HRAS—rectum cancer	0.00388	0.0107	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by Interleukins—NRAS—rectum cancer	0.00387	0.0107	CbGpPWpGaD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—TP53—rectum cancer	0.00369	0.0102	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by Interleukins—KRAS—rectum cancer	0.00333	0.0092	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—NRAS—rectum cancer	0.00322	0.00888	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—NRAS—rectum cancer	0.00308	0.00852	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00304	0.0084	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—NRAS—rectum cancer	0.00285	0.00788	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by Interleukins—HRAS—rectum cancer	0.00283	0.00782	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—KRAS—rectum cancer	0.00277	0.00764	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—TP53—rectum cancer	0.00276	0.00762	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00269	0.00744	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—KRAS—rectum cancer	0.00265	0.00733	CbGpPWpGaD
Pseudoephedrine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—rectum cancer	0.00254	0.00702	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—TP53—rectum cancer	0.00246	0.00679	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—KRAS—rectum cancer	0.00245	0.00678	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TYMS—rectum cancer	0.00234	0.00646	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—HRAS—rectum cancer	0.00226	0.00623	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—rectum cancer	0.00214	0.0059	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.00211	0.00582	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—HRAS—rectum cancer	0.00209	0.00576	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—rectum cancer	0.00184	0.00508	CbGpPWpGaD
Pseudoephedrine—TNF—TGF-beta Receptor Signaling—HRAS—rectum cancer	0.00184	0.00507	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—NRAS—rectum cancer	0.00181	0.00499	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—NRAS—rectum cancer	0.00164	0.00452	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—TP53—rectum cancer	0.00163	0.00451	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—rectum cancer	0.00156	0.00432	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—KRAS—rectum cancer	0.00156	0.00429	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—ITGA2—rectum cancer	0.00152	0.0042	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—TP53—rectum cancer	0.00142	0.00391	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—KRAS—rectum cancer	0.00141	0.00389	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—rectum cancer	0.00135	0.00372	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—HRAS—rectum cancer	0.00132	0.00365	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—HRAS—rectum cancer	0.0012	0.00331	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—NRAS—rectum cancer	0.0012	0.00331	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—NRAS—rectum cancer	0.00113	0.00311	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—rectum cancer	0.00108	0.00297	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—KRAS—rectum cancer	0.00103	0.00285	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—rectum cancer	0.00103	0.00284	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—NRAS—rectum cancer	0.00101	0.00279	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—KRAS—rectum cancer	0.000969	0.00268	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—ITGA2—rectum cancer	0.000945	0.00261	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—HRAS—rectum cancer	0.000877	0.00242	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—KRAS—rectum cancer	0.000871	0.0024	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—rectum cancer	0.000861	0.00238	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—rectum cancer	0.000826	0.00228	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—HRAS—rectum cancer	0.000824	0.00227	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000786	0.00217	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—rectum cancer	0.000776	0.00214	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—rectum cancer	0.000774	0.00214	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000699	0.00193	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—NRAS—rectum cancer	0.000698	0.00193	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—NRAS—rectum cancer	0.000646	0.00178	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NRAS—rectum cancer	0.000644	0.00178	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000611	0.00169	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—KRAS—rectum cancer	0.000601	0.00166	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—NRAS—rectum cancer	0.00059	0.00163	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000568	0.00157	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—rectum cancer	0.000567	0.00157	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—KRAS—rectum cancer	0.000556	0.00154	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—KRAS—rectum cancer	0.000555	0.00153	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HRAS—rectum cancer	0.000511	0.00141	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—KRAS—rectum cancer	0.000508	0.0014	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—rectum cancer	0.000488	0.00135	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HRAS—rectum cancer	0.000473	0.00131	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HRAS—rectum cancer	0.000471	0.0013	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—HRAS—rectum cancer	0.000468	0.00129	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NRAS—rectum cancer	0.000451	0.00125	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—HRAS—rectum cancer	0.000435	0.0012	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HRAS—rectum cancer	0.000432	0.00119	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—NRAS—rectum cancer	0.000427	0.00118	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—rectum cancer	0.000415	0.00114	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—KRAS—rectum cancer	0.000388	0.00107	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NRAS—rectum cancer	0.000382	0.00105	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TYMS—rectum cancer	0.000372	0.00103	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—KRAS—rectum cancer	0.000368	0.00101	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—rectum cancer	0.000345	0.000953	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HRAS—rectum cancer	0.00033	0.000911	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—KRAS—rectum cancer	0.000328	0.000907	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—HRAS—rectum cancer	0.000312	0.000862	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—rectum cancer	0.000292	0.000806	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HRAS—rectum cancer	0.000279	0.000771	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NRAS—rectum cancer	0.000266	0.000733	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TYMS—rectum cancer	0.000248	0.000686	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—KRAS—rectum cancer	0.000229	0.000631	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—rectum cancer	0.000203	0.000561	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—NRAS—rectum cancer	0.000203	0.00056	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—NRAS—rectum cancer	0.000198	0.000548	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HRAS—rectum cancer	0.000194	0.000536	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—KRAS—rectum cancer	0.000174	0.000482	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—KRAS—rectum cancer	0.000171	0.000471	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—NRAS—rectum cancer	0.000164	0.000453	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TYMS—rectum cancer	0.000162	0.000447	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—NRAS—rectum cancer	0.000152	0.000421	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HRAS—rectum cancer	0.000148	0.000409	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HRAS—rectum cancer	0.000145	0.000401	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—KRAS—rectum cancer	0.000141	0.00039	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—KRAS—rectum cancer	0.000131	0.000362	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HRAS—rectum cancer	0.00012	0.000331	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NRAS—rectum cancer	0.00012	0.000331	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NRAS—rectum cancer	0.000117	0.000323	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HRAS—rectum cancer	0.000111	0.000308	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KRAS—rectum cancer	0.000103	0.000285	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KRAS—rectum cancer	0.000101	0.000278	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NRAS—rectum cancer	9.69e-05	0.000268	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—rectum cancer	9.16e-05	0.000253	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NRAS—rectum cancer	9e-05	0.000249	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—rectum cancer	8.96e-05	0.000247	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HRAS—rectum cancer	8.76e-05	0.000242	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HRAS—rectum cancer	8.57e-05	0.000237	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KRAS—rectum cancer	8.34e-05	0.00023	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KRAS—rectum cancer	7.75e-05	0.000214	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—rectum cancer	7.41e-05	0.000205	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HRAS—rectum cancer	7.09e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—rectum cancer	6.89e-05	0.00019	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HRAS—rectum cancer	6.59e-05	0.000182	CbGpPWpGaD
